A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
Fankhauser CD, Parry MG, Ali A, Cowling TE, Nossiter J, Sujenthiran A, Berry B, Morris M, Aggarwal A, Payne H, van der Meulen J, Clarke NW.
Fankhauser CD, et al. Among authors: cowling te.
Eur J Cancer. 2023 Mar;181:70-78. doi: 10.1016/j.ejca.2022.12.017. Epub 2022 Dec 26.
Eur J Cancer. 2023.
PMID: 36641896
Free article.